ENTO

Entero Therapeutics, Inc. · NASDAQ

Sector Health Technology
Industry Biotechnology
Website -
Employees(FY) -
ISIN US33749P4081

Performance

-40.57%

1W

-52.14%

1M

-68.86%

3M

-77.76%

6M

-70.71%

YTD

-96.03%

1Y

Profile

-

Advanced Technical Analysis

Technical Analysis of ENTO 2024-05-31

Overview:

In analyzing the technical indicators for ENTO over the last 5 days, we will delve into the trend, momentum, volatility, and volume indicators to provide a comprehensive outlook on the possible stock price movement in the coming days.

Trend Analysis:

Moving Averages (MA): The 5-day MA has been consistently decreasing, indicating a dow...

Recent News & Updates

2023-12-05 18:00
First Wave BioPharma to Participate in BIO Partnering @JPM During J.P. Morgan Week 2024(Globenewswire)
2023-12-04 18:00
First Wave BioPharma CEO James Sapirstein to Moderate Panel Discussion at Longwood Healthcare Leaders Conference(Globenewswire)
2023-10-09 19:00
Date and Time Announced for First Wave BioPharma CEO James Sapirstein's Presentation at the 2023 BIO Investor Forum(Globenewswire)
2023-10-02 19:00
First Wave BioPharma CEO James Sapirstein to Present at the 2023 Roth Healthcare Opportunities Conference(Globenewswire)
2023-09-14 20:45
First Wave BioPharma To Present at the BIO Investor Forum(Yahoo Finance)
2023-09-13 22:43
First Wave BioPharma Announces Exercise of Warrants and Issuance of New Warrants in a Private Placement for $4.0 Million Gross Proceeds Priced At-the-Market(Yahoo Finance)
2023-09-13 18:00
First Wave BioPharma Announces Exclusive Global License Agreement for Capeserod from Sanofi(Yahoo Finance)
2023-09-04 19:00
First Wave BioPharma to Participate in the H.C. Wainwright 25th Annual Global Investment Conference(Yahoo Finance)
2023-07-18 20:15
First Wave BioPharma, Inc. Announces Pricing of $2.1 Million Public Offering(Yahoo Finance)
2023-07-12 19:00
First Wave BioPharma Announces Initial Topline Results from Phase 2 SPAN Clinical Trial Investigating Enhanced Adrulipase Formulation(Yahoo Finance)
2023-07-04 19:00
First Wave BioPharma Chairman and CEO Issues Letter to Stockholders(Yahoo Finance)
2023-06-27 19:00
First Wave BioPharma Announces Final Patient Dosed in Phase 2 SPAN Clinical Trial of Enhanced Adrulipase Formulation(Yahoo Finance)
2023-06-26 19:00
First Wave BioPharma Strengthens Intellectual Property Estate(Yahoo Finance)
2023-06-14 23:31
First Wave BioPharma to Attend the 36th National Cystic Fibrosis Education Conference (July 28-30)(Yahoo Finance)
2023-06-13 00:50
First Wave BioPharma Announces Exercise of Warrants and Issuance of New Warrants in a Private Placement for $2.4 Million Gross Proceeds Priced At-the-Market(Yahoo Finance)
2023-06-12 19:00
First Wave BioPharma Reaches Enrollment Target for Phase 2 SPAN Adrulipase Clinical Trial in Cystic Fibrosis(Yahoo Finance)
2023-05-14 19:00
First Wave BioPharma CEO James Sapirstein to Present at 2023 BIO International Conference(Yahoo Finance)
2023-05-10 19:00
First Wave BioPharma Completes Patient Screening For Phase 2 Span Adrulipase Clinical Trial in Cystic Fibrosis(Yahoo Finance)
2023-05-01 19:30
First Wave BioPharma to Participate in EF Hutton Inaugural Global Conference(Yahoo Finance)
2023-04-24 19:00
First Wave Biopharma Exceeds 50% Enrollment Target for Phase 2 Span Adrulipase Clinical Trial in Cystic Fibrosis(Yahoo Finance)
2023-03-12 20:00
First Wave BioPharma Announces $4.0 Million Private Placement Priced At-The-Market under Nasdaq Rules(Yahoo Finance)
2023-03-12 19:00
HOOKIPA Pharma Appoints Terry Coelho to its Board of Directors(Yahoo Finance)
2023-03-09 18:00
First Wave BioPharma Announces Second Patient Dosed in Phase 2 SPAN Clinical Trial of Enhanced Adrulipase Formulation in Cystic Fibrosis(Yahoo Finance)
2023-03-08 18:00
First Wave BioPharma Announces First Patient Dosed in Phase 2 SPAN Clinical Trial of Enhanced Adrulipase Formulation(Yahoo Finance)
2023-02-27 18:00
First Wave BioPharma to Participate in Fireside Chat at the 35th Annual Roth Conference(Yahoo Finance)
2023-02-20 18:00
First Wave BioPharma Announces Phase 2 Adrulipase Combination Trial Data to be Presented at the 2023 Digestive Disease Week (DDW) Conference(Yahoo Finance)
2023-02-12 18:00
First Wave BioPharma Chairman and CEO Issues Letter to Stockholders(Yahoo Finance)
2023-02-06 18:00
First Wave BioPharma Regains Compliance With Nasdaqs Minimum Bid Price Requirement(Yahoo Finance)
2023-02-01 18:00
First Wave BioPharma Announces First Patient Screened for Phase 2 SPAN Adrulipase Trial in Cystic Fibrosis(Yahoo Finance)
2023-01-30 18:00
First Wave BioPharma Announces Initiation of Phase 2 Trial Investigating Enhanced Adrulipase Formulation in Exocrine Pancreatic Insufficiency in Patients with Cystic Fibrosis(Yahoo Finance)

Page 2 of 4

previous next